Live Breaking News & Updates on Jeffrey Robert Ajer|Page 5

Stay updated with breaking news from Jeffrey robert ajer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cannon Global Investment Management LLC Purchases Shares of 5,000 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Cannon Global Investment Management LLC acquired a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,000 shares of the biotechnology company’s stock, valued at approximately $433,000. BioMarin Pharmaceutical […] ....

George Eric Davis , Stifel Nicolaus , Jeffrey Robert Ajer , Cannon Global Investment Management , Exchange Commission , Acadian Asset Management , Biomarin Pharmaceutical Inc , Group Wealth Management , Grey Fox Wealth Advisors , Securities Exchange Commission , Maytech Global Investments , Biomarin Pharmaceutical , Free Report , Marin Pharmaceutical , Fox Wealth Advisors , Wealth Management , Asset Management , Eric Davis , Robert Ajer , Marin Pharmaceutical Trading Down , Get Free Report , Marin Pharmaceutical Inc , Visit Holdingschannel , Biomarin Pharmaceutical Daily , Nasdaq Bmrn , Sec Filings ,

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) EVP Sells $450,000.00 in Stock

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) EVP Jeffrey Robert Ajer sold 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $90.00, for a total value of $450,000.00. Following the completion of the sale, the executive vice president now […] ....

Jeffrey Robert Ajer , Avoro Capital Advisors , Vanguard Group Inc , Biomarin Pharmaceutical Company Profile , Ameriprise Financial Inc , Norges Bank , Biomarin Pharmaceutical Inc , Geode Capital Management , Biomarin Pharmaceutical , Get Free Report , Robert Ajer , Marin Pharmaceutical Stock Down , Marin Pharmaceutical , Capital Advisors , Capital Management , Marin Pharmaceutical Inc , Biomarin Pharmaceutical Daily , Nasdaq Bmrn , Insider Trading , Nsider Trades ,

BioMarin Pharmaceutical (BMRN) to Release Quarterly Earnings on Wednesday

BioMarin Pharmaceutical (NASDAQ:BMRN – Get Rating) is set to issue its quarterly earnings data after the market closes on Wednesday, April 26th. Analysts expect the company to announce earnings of $0.43 per share for the quarter. BioMarin Pharmaceutical has set its FY 2023 guidance at $1.80-$2.05 EPS.Individual that wish to register for the company’s earnings […] ....

United States , Jeffrey Robert Ajer , Jean Jacques Bienaime , Johnc Klock , Resurgent Financial Advisors , Biomarin Pharmaceutical Company Profile , Maytech Global Investments , Biomarin Pharmaceutical Inc , Acadian Asset Management , Morgan Stanley , Securities Exchange Commission , Group Wealth Management , Biomarin Pharmaceutical , Get Rating , Marin Pharmaceutical , Marin Pharmaceutical Stock Down , Robert Ajer , Jacques Bienaime , Exchange Commission , Wealth Management , Asset Management , Tech Global Investments , Biomarin Pharmaceutical Daily , Nasdaq Bmrn ,